According to @StockMKTNewz, Eli Lilly (LLY) generated $59.4 billion in revenue over the last 12 months, up from $24.5 billion in 2020 (source: @StockMKTNewz). This equates to roughly 2.4x top-line growth since 2020, highlighting a materially higher revenue run-rate that traders can benchmark in valuation and momentum screens (source: @StockMKTNewz). The update is revenue-only and does not reference crypto assets such as BTC or ETH, so any crypto market impact is not specified by the source (source: @StockMKTNewz).